These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30542324)

  • 1. Role of Endocrine-Disrupting Engineered Nanomaterials in the Pathogenesis of Type 2 Diabetes Mellitus.
    Priyam A; Singh PP; Gehlout S
    Front Endocrinol (Lausanne); 2018; 9():704. PubMed ID: 30542324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hidden Threat: Endocrine Disruptors and Their Impact on Insulin Resistance.
    Dagar M; Kumari P; Mirza AMW; Singh S; Ain NU; Munir Z; Javed T; Virk MFI; Javed S; Qizilbash FH; Kc A; Ekhator C; Bellegarde SB
    Cureus; 2023 Oct; 15(10):e47282. PubMed ID: 38021644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate.
    Zhu M; Nie G; Meng H; Xia T; Nel A; Zhao Y
    Acc Chem Res; 2013 Mar; 46(3):622-31. PubMed ID: 22891796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradations of endocrine-disrupting chemicals and pharmaceutical compounds in wastewater with carbon-based nanomaterials: a critical review.
    Ojha A; Tiwary D; Oraon R; Singh P
    Environ Sci Pollut Res Int; 2021 Jun; 28(24):30573-30594. PubMed ID: 33909248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
    Holden PA; Nisbet RM; Lenihan HS; Miller RJ; Cherr GN; Schimel JP; Gardea-Torresdey JL
    Acc Chem Res; 2013 Mar; 46(3):813-22. PubMed ID: 23039211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of nanomaterial characteristics on inhalation toxicity.
    Bierkandt FS; Leibrock L; Wagener S; Laux P; Luch A
    Toxicol Res (Camb); 2018 May; 7(3):321-346. PubMed ID: 30090585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants-A Review.
    Kowalczyk M; Piwowarski JP; Wardaszka A; Średnicka P; Wójcicki M; Juszczuk-Kubiak E
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxicity induced by engineered nanomaterials.
    Ge D; Du Q; Ran B; Liu X; Wang X; Ma X; Cheng F; Sun B
    Int J Nanomedicine; 2019; 14():4167-4186. PubMed ID: 31239675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outdoor urban nanomaterials: The emergence of a new, integrated, and critical field of study.
    Baalousha M; Yang Y; Vance ME; Colman BP; McNeal S; Xu J; Blaszczak J; Steele M; Bernhardt E; Hochella MF
    Sci Total Environ; 2016 Jul; 557-558():740-53. PubMed ID: 27046139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecophysiological perspectives on engineered nanomaterial toxicity in fish and crustaceans.
    Callaghan NI; MacCormack TJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2017 Mar; 193():30-41. PubMed ID: 28017784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus: Plasticizers and nanomaterials acting as endocrine-disrupting chemicals (Review).
    Tuculina MJ; Perlea P; Gheorghiță M; Cumpătă CN; Dascălu IT; Turcu A; Nicola AG; Gheorghiță LM; Diaconu OA; Valea A; Ghemigian A; Carsote M
    Exp Ther Med; 2022 Apr; 23(4):288. PubMed ID: 35317436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine Disrupting Chemicals Mediated through Binding Androgen Receptor Are Associated with Diabetes Mellitus.
    Sakkiah S; Wang T; Zou W; Wang Y; Pan B; Tong W; Hong H
    Int J Environ Res Public Health; 2017 Dec; 15(1):. PubMed ID: 29295509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proteome-wide assessment of the oxidative stress paradigm for metal and metal-oxide nanomaterials in human macrophages.
    Zhang T; Gaffrey MJ; Thomas DG; Weber TJ; Hess BM; Weitz KK; Piehowski PD; Petyuk VA; Moore RJ; Qian WJ; Thrall BD
    NanoImpact; 2020 Jan; 17():. PubMed ID: 32133426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered nanomaterials for plant growth and development: A perspective analysis.
    Verma SK; Das AK; Patel MK; Shah A; Kumar V; Gantait S
    Sci Total Environ; 2018 Jul; 630():1413-1435. PubMed ID: 29554761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine disruptors in plastics alter β-cell physiology and increase the risk of diabetes mellitus.
    Martínez-Pinna J; Sempere-Navarro R; Medina-Gali RM; Fuentes E; Quesada I; Sargis RM; Trasande L; Nadal A
    Am J Physiol Endocrinol Metab; 2023 Jun; 324(6):E488-E505. PubMed ID: 37134142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ONE Nano: NIEHS's strategic initiative on the health and safety effects of engineered nanomaterials.
    Schug TT; Johnson AF; Balshaw DM; Garantziotis S; Walker NJ; Weis C; Nadadur SS; Birnbaum LS
    Environ Health Perspect; 2013 Apr; 121(4):410-4. PubMed ID: 23407114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered nanomaterials and oxidative stress: current understanding and future challenges.
    Mendoza RP; Brown JM
    Curr Opin Toxicol; 2019 Feb; 13():74-80. PubMed ID: 31263794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence.
    Kurşunoğlu NE; Sarer Yurekli BP
    World J Clin Cases; 2022 Nov; 10(31):11226-11239. PubMed ID: 36387809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
    Wan MLY; Co VA; El-Nezami H
    Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.